Journals / The Journal of Pediatric Research / 2020 / Cilt: 7 - Sayı: 2

Community-acquired Pediatric Urinary Tract Infections Caused by Morganella Morganii

Pages
121–125
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As in other infections, antibiotic susceptibility profiles are crucial in directing treatment .

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Escherichia coli is the most common microorganism recovered in urinary tract infections (UTI) in all age groups.
📊
Key Findings & Data:The aim of this study was to investigate children with UTI caused by Morganellamorganii.Materials and Methods: Children with UTI caused by Morganella morganii in our pediatric outpatient clinic were retrospectively evaluated.Results: The mean age of 11 children was 4.2±1.9 years (minimum: 19 months, maximum: 7.5 years).
💡
Conclusion & Impact:As in other infections, antibiotic susceptibility profiles are crucial in directing treatment .
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Aim: Escherichia coli is the most common microorganism recovered in urinary tract infections (UTI) in all age groups. Lately, different pathogens,such as Morganella morganii, are beginning to be isolated. The aim of this study was to investigate children with UTI caused by Morganellamorganii.Materials and Methods: Children with UTI caused by Morganella morganii in our pediatric outpatient clinic were retrospectively evaluated.Results: The mean age of 11 children was 4.2±1.9 years (minimum: 19 months, maximum: 7.5 years). Four (36.4%) patients were female. Themost frequent symptoms were irritability (n=5, 45.5%) and dysuria (n=5, 45.5%). Urinalysis was positive for leukocytes in 9 (81.8%), hematuriain 5 (45.5%), and nitrite in 6 (54.5%) patients. None of the patients had electrolyte abnormalities or renal failure. Colony count was mostprevalently 100,000 colony-forming unit/mL (n=7,63.6%). The pathogen was most sensitive to imipenem/meropenem and piperacillintazobactam(n=11, 100%, for both). Two (18.1%) patients were hospitalized. Empirical antibiotic treatments were switched to amikacin (15 mg/kg/day) for outpatients and piperacillin-tazobactam (300 mg/kg/day) for hospitalized patients for 10 days. Repeat urine cultures on the thirdday of treatment were negative.Conclusion: Morganella morganii, which is usually encountered as a kind of nosocomial or opportunistic infection, is presented as a cause ofcommunity-acquired UTI in this study. As in other infections, antibiotic susceptibility profiles are crucial in directing treatment .

🔖

Cite This Article

ATMIŞ, B., KARA, S. S., ASLAN, M. H. (2020). Community-acquired Pediatric Urinary Tract Infections Caused by Morganella Morganii. The Journal of Pediatric Research, Cilt: 7 - Sayı: 2, 121–125. https://ajindex.com/articles/362717

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Shaikh N, Morone NE, Bost JE, Farrell MH. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J 2008;27:302-8
  2. Gür D, Kanra G, Ceyhan M, Seçmeer G, Kanra B, Kaymakoğlu I. Epidemiology and antibiotic resistance of gram-negative urinary pathogens in pediatric patients. Turkish J Pediatrics 1999;41:37-42
  3. O’Hara CM, Brenner FW, Miller JM. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev 2000;13:534-46
  4. Liu H, Zhu J, Hu Q, Rao X. Morganella morganii, a non-negligent opportunistic pathogen. Int J Infect Dis 2016;50:10-7
  5. Johnson JR, Feingold M. Case of chorioamnionitis in an immunocompetent woman caused by Morganella morganii. J Matern Fetal Med 1998;7:13-4
  6. Tsanaktsidis G, Agarwal SA, Maloof AJ, Chandra J, Mitchell P. Postoperative Morganella morganii endophthalmitis associated with subclinical urinary tract infection. J Cataract Refract Surg 2003;29:1011-3
  7. Cetin M, Ocak S, Kuvandik G, Aslan B, Temiz M, Aslan A. Morganella morganii-associated arthritis in a diabetic patient. Adv Ther 2008;25:240-4
  8. Chen YT, Peng HL, Shia WC, et al. Whole-genome sequencing and identification of Morganella morganii KT pathogenicityrelated genes. BMC Genomics 2012;13Suppl 7:S4
  9. Hodson EM, Craig JC. Urinary tract infections in children. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein SL (eds). Pediatric Nephrology. Seventh Edition. Berlin, Springer-Verlag, 2016:1695-714
  10. Lin TY, Chan MC, Yang YS, et al. Clinical manifestations and prognostic factors of Morganella morganii bacteremia. Eur J Clin Microbiol Infect Dis 2015;34:231-6
  11. Nasri YM, Denden RI, Guo Q, Mastouri M, Aouni M, Wang M. Type II and type IV topoisomerase mutations in clinical isolates of Morganella morganii harbouring the qnrD gene. Ann Clin Microbiol Antimicrob 2014;13:34
  12. Koyuncu S, Ozan F. Morganella morganii osteomyelitis complicated by secondary septic knee arthritis: a case report. Acta Orthop Traumatol Turc 2012;46:464-7
  13. Atalay H, Güney I, Solak Y, Almaz E. First case of CAPDrelated peritonitis caused by Morganella morganii. Perit Dial Int 2010;30:119-21
  14. Erlanger D, Assous MV, Wiener-Well Y, Yinnon AM, Ben-Chetrit E. Clinical manifestations, risk factors and prognosis of patients with Morganella morganii sepsis. J Microbiol Immunol Infect 2019;52:443-8
  15. Falagas ME, Kavvadia PK, Mantadakis E, et al. Morganella morganii infections in a